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The traditional view of sexual differentiation of the mammalian
brain holds that sex differences in the brain and behaviour develop
under the influence of gonadal hormones, with the male brain
developing under the influence of testosterone secreted by the
male’s testes, and the female brain in the absence of these hor-
mones. Accordingly, McEwen et al. (1) proposed that the female
rodent brain needs to be protected from any oestrogens produced
by the placenta or by male siblings lying in close approximation,
and that a-fetoprotein (AFP), comprising an important plasma pro-
tein present during foetal development in high concentrations, is
the most likely candidate to achieve this protection because of its
high oestrogen-binding capacities. This idea of a default organisa-
tional programme for the female brain as well as a protective role
for AFP has been challenged. First, there is some behavioural evi-
dence indicating that the normal sexual differentiation of the
female brain requires oestradiol (2, 3) and, second, the presence of
AFP within neurones in the absence of any local AFP synthesis sug-
gests that AFP can enter the brain. It was therefore proposed by
Toran-Allerand (4) that AFP can actually act as a carrier transport-
ing oestradiol into the brain and, by doing so, participates in the
sexual differentiation of the female brain. Thus, there have been
two opposing hypotheses on the role of AFP and oestradiol in the
development of the female brain.
However, we have recently been able to resolve this longstanding
dilemma about the role of AFP in brain sexual differentiation using
a knockout mouse model for AFP (AFP-KO) (5). Female AFP-KO mice
were clearly defeminised with regard to their lordosis behaviour as
well as their population of tyrosine hydroxylase neurones in the
sexually differentiated anteroventral periventricular area (AVPV) of
the hypothalamus, although these behavioural and morphological
consequences of the AFP mutation could be reversed by transpla-
cental treatment with an aromatase-inhibiting drug, 1,4,6-androst-
atriene-3,17-dione (ATD) (6). These results thus confirmed that
circulating AFP binds oestradiol in female foetuses so as to protect
their brains from the potential defeminising effects of this hormone
that would normally occur in the male brain in response to oestra-
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A central tenet of contemporary theories on mammalian brain and behavioural sexual differenti-
ation is that an organisational action of testosterone, secreted by the male’s testes, controls
male-typical aspects of brain and behavioural development, whereas no active perinatal sex hor-
mone signalling is required for female-typical sexual differentiation. Furthermore, the available
evidence suggests that many, although not all, of the perinatal organisational actions of testos-
terone on the development of the male brain result from the cellular effects of oestradiol
formed via neural aromatisation of testosterone. However, a default developmental programme
for the female brain has been criticised. Indeed, we review new results obtained in aromatase
knockout mice indicating that oestradiol actively contributes to the differentiation of female-
typical aspects of brain and behavioural sexual differentiation. Furthermore, we propose that
male-typical neural and behavioural differentiation occurs prenatally in genetic males under the
influence of oestradiol, which is avoided in foetal genetic females by the neuroprotective actions
of a-fetoprotein, whereas female-typical neural and behavioural differentiation normally occurs
postnatally in genetic females under the influence of oestradiol that is presumably produced by
the ovaries.
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Although the results obtained in AFP-KO female mice suggest
that the principal action of prenatal oestrogen exposure, regardless
of whether it occurs in female or male mice, is to defeminise, and
to some extent, masculinise the brain and behaviour, there is
increasing evidence for a feminising role of oestradiol in the devel-
opment of the female brain. Indeed, in this review, we present
results obtained in aromatase knockout (ArKO) mice showing that
oestradiol can have feminising actions on the brain and behaviour.
On the basis of the results obtained in both knockout mouse mod-
els (i.e. the ArKO and AFP-KO mouse), we propose that the defe-
minising actions of oestradiol normally occur prenatally in males
and are avoided in foetal females because of the protective actions
of AFP, whereas the feminising actions of oestradiol normally occur
postnatally in genetic females, perhaps when the ovaries start to
produce oestrogens (i.e. in the second week after birth) and when
circulating concentrations of AFP have diminished so that AFP no
longer plays a protective role.
Classical theory of brain and behavioural sexual
differentiation
In male mammals, the presence of the Sry gene on the Y-chromo-
some causes the undifferentiated gonads to develop into testes
instead of ovaries (7). Testosterone secreted by testicular Leydig
cells promotes the development of the Wolffian ducts into the
internal male genital structures, whereas anti-Müllerian hormone
secreted by testicular Sertoli cells causes regression of the female-
typical Müllerian ducts. The penis and scrotum develop under the
influence of dihydrotestosterone, which is formed from testosterone
by the enzyme, 5a-reductase. In normal female differentiation, the
Müllerian ducts develop without any apparent hormonal input into
the uterus, fallopian tubes and the distal portion of the vagina. The
Wolffian ducts regress and disappear in the absence of androgenic
stimulation. A seminal study by Phoenix et al. (8) provided the first
evidence that the capacity to display sex-specific behaviours in
adulthood (and, by inference, the sexual differentiation of the brain)
follows the same pattern as that of the genitals. Thus, female gui-
nea pigs treated with testosterone propionate prenatally showed
increased levels of male-typical mounting behaviour together with
reduced levels of female-typical lordosis behaviour in adulthood
after hormonal priming (8). Supportive evidence for a role of peri-
natal testosterone in the development of the male brain came from
subsequent studies by Baum (9) and many others (10, 11) demon-
strating that the removal of testosterone by neonatal castration
reduced males’ later capacity to show male sexual behaviours at
the same time as enhancing their ability to show female sexual
behaviours. Additional evidence suggested that testosterone
secreted by the testes acts perinatally, either directly via androgen
receptors or after being aromatised into oestradiol and stimulating
oestradiol receptors (12, 13), to masculinise (enhance male-typical
sexual responses) and ⁄ or defeminise (suppress female-typical sexual
responses) the neural substrate that controls sexual behaviour in
adulthood. The results of these early studies also implied that the
neural mechanisms that control later female-typical sexual behav-
iour normally develop perinatally in females ‘by default’ (i.e. without
the need for any sex steroid stimulation). Consistent with this view
is the observation (14) that the rodent ovary does not secrete sig-
nificant amounts of oestradiol before postnatal day 7, and that any
oestrogens secreted by the mother during gestation will not be
available to the foetal (male or female) brain because they are
bound with high affinity and capacity to AFP, a plasma glycoprotein
produced in high quantities by the foetal liver (15, 16). Thus, it was
proposed by McEwen et al. (1) that AFP serves to protect the devel-
oping female brain from becoming masculinised and ⁄ or defemin-
ised by any oestradiol originating from their mother or male
siblings lying in close approximation. This hypothesis on a protec-
tive role for AFP was recently confirmed by our research group
using AFP-KO mice (6).
Role of oestradiol in female-typical brain and
behavioural sexual differentiation
The possible importance of ovarian hormones in female-typical brain
sexual differentiation was first suggested by some early behavioural
studies (3, 17) in which it was shown that female rats ovariectomised
on the day of birth had lower lordosis quotients after adult treatment
with oestradiol and progesterone than females that either kept their
ovaries (17) or were ovariectomised at birth and at the same time
implanted with ovaries until postnatal day 60 (3). In addition, Toran-
Allerand (18) reported that oestradiol promoted neurite outgrowth
from foetal hypothalamic explants of both sexes, suggesting a role
for oestradiol in neural differentiation. More recently, Dohler et al.
(19) showed that neonatal treatment of female rats with tamoxifen,
an oestrogen receptor antagonist, decreased their later capacity to
show lordosis behaviour, whereas concurrent neonatal adminis-
tration of a low dose of oestradiol benzoate (EB) prevented this
effect. Finally, Baum and Tobet (20) found that female ferrets treated
prenatally with the aromatase inhibitor, ATD, and then treated in
adulthood with a low or moderate dose of EB, displayed decreased
acceptance quotients when paired with a stimulus male.
These various behavioural results suggested that exposure to a
low level of oestradiol over a postnatal interval between birth and
the age of puberty facilitated the later capacity to display female
sexual behaviour; however, they did not provide incontrovertible
evidence that oestradiol normally contributes to the development
of female sexual behaviour in female mammals. First, the effects of
neonatal ovariectomy on the potential to show lordosis behaviour
later in life were only transient because any differences in lordosis
behaviour disappeared after repeated testing (3). Perhaps more
importantly, in addition to its anti-oestrogenic actions, tamoxifen
can exert oestrogen-like agonist actions in the brain (21). Therefore,
the observed reduction in lordosis behaviour induced by administer-
ing tamoxifen neonatally to female rats (19) may actually have
resulted from a partial defeminisation of the brain by the oestra-
diol-like actions of tamoxifen acting on neural oestradiol receptors.
Finally, prenatally ATD-treated female ferrets and control females
displayed equivalent, high, acceptance quotients when tested after
receiving a high dose of EB in adulthood (20), again indicating that
ATD-treated females were capable of displaying normal female-typi-
cal receptive behaviour. Thus, it has been difficult to provide con-
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clusive evidence of a role for oestrogens in the development of the
female brain. As a result, the hypothesis languished since the mid-
1980s as a result of the absence of a suitable animal model in
which to assess rigorously the possible contribution of oestradiol.
The creation of the ArKO mouse (22, 23) provided an opportunity
to reopen work on this hypothesis. Because ArKO mice cannot pro-
duce oestrogens themselves as a result of a targeted mutation in
the aromate (Cyp19) gene, but do have functional oestrogen recep-
tors, they can respond to exogenous oestradiol at any time during
their life span. This means that this model can be used to distin-
guish between organisational and activational effects of oestradiol
on brain and behavioural functions. Here, we present a short over-
view of the results obtained in the ArKO mouse model that provide
evidence for a role of oestradiol in female neural and behavioural
differentiation.
Reduced female sexual behaviour in female ArKO mice
In a first experiment, we determined whether lordosis behaviour
was affected in female ArKO mice (24). If the female brain indeed
develops in the absence of any oestradiol, ArKO female mice should
show normal, wild-type levels of lordosis behaviour, provided that
they are supplemented with ovarian hormones, such as oestradiol
and progesterone, in adulthood because they cannot produce oes-
tradiol. In addition, progesterone levels are affected in ArKO females
(22) because they do not show any signs of ovulation (25). Indeed,
their ovaries contain follicles but no corpora lutea. In addition, dur-
ing puberty, their ovaries appear to develop some testicular tissue,
as demonstrated by the presence of Sertoli and Leydig cells, sug-
gesting that oestrogens are not only necessary for folliculogenesis,
but also to maintain ovarian morphology. Adult treatment with
oestradiol restores ovarian morphology in ArKO females (26), but
fails to induce ovulation (27). We observed that ArKO females
showed less lordotic responses when mounted by the stimulus male
(Fig. 1A). There was no genotype differences in the number of
mounts received. In addition, this reduction in lordosis behaviour
did not disappear with repeated testing as was observed in the
early studies using neonatally ovariectomised female rats (3), sug-
gesting thus permanent effects of early oestradiol deprivation on
the later ability to show lordosis behaviour.
The absence of lordosis behaviour in ArKO females might have
been caused by a partial defeminisation of the brain as a result of
the presence of phytoestrogens in the food. By contrast to natural
oestrogens, phytoestrogens are generally nonsteroidal and thus
have lower affinities for oestradiol-binding plasma proteins such as
AFP. They may thus evade the protective actions of AFP and freely
enter the brain to interfere with the development of the neural cir-
cuits involved in later sexual behaviour. However, these experiments
on lordosis behaviour in ArKO females have been repeated when
feeding all subjects, including ArKO mice, phytoestrogen-free food
(phytoestrogen-free mouse chow D10001 AIN-76A; Brogaarden,
Lynge, Denmark) and very similar results were obtained (i.e. a clear
significant reduction in lordosis behaviour in ArKO females com-
pared to wild-type females) (O Brock, M.J. Baum, and J. Bakker,
unpublished results).
Another possible explanation for reduced levels of lordosis
behaviour in ArKO females could be that they have been partially
masculinised by increased concentrations of testosterone during
early development. Fisher et al. (22) reported that ArKO mice (a dif-
ferent knockout model than the one used in our studies) of both
sexes are exposed to increased plasma levels of testosterone during
adulthood. These increased levels of testosterone probably results
from the lack of negative-feedback action of oestradiol on the
hypothalamic-pituitary-gonadal axis, as suggested by the increased
levels of circulating luteinising hormone (LH) and follicle stimulating
























































Fig. 1. Sexual behaviour of female wild-type and aromatase knockout
(ArKO) mice. (A) Mean  SEM lordosis quotients calculated by dividing the
number of lordotic responses shown by the number of mounts received
from the stimulus male (·100%). *P < 0.05 compared to wild-type (WT)
females. (B) Mean  SEM number of mounts (including mounts with intro-
mission-like movements) displayed with an oestrous female. Females were
first tested with testosterone and then with testosterone and oestradiol. The
dotted line represents number of mounts and intromissions displayed by
gonadally intact wild-type male mice under similar testing conditions (48)
*P < 0.05 compared to ArKO females. Data adapted from Bakker et al. (24).
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testosterone could be the result of an accumulation of the andro-
genic substrate because it is no longer aromatised to oestradiol as
a result of targeted mutation in the aromatase gene. Because the
foetal and neonatal ovaries are not producing high levels of steroid
hormones, as well as there being little evidence that the HPG axis
is active during early development (28), it is unlikely that this
increase in testosterone levels also takes place during early devel-
opment; however, because no data are available at present to eval-
uate this question, it could be speculated that increased levels of
testosterone contribute to the development of the behavioural phe-
notype of ArKO female mice. Therefore, to evaluate whether the
reduction in lordosis behaviour in ArKO females reflects the mascu-
linising and defeminising actions of testosterone on their brains
during early development, female wild-type and ArKO mice were
tested for their ability to show male-typical mounting behaviour
with an oestrous female. After 3 weeks of testosterone treatment,
female ArKO mice showed very little mounting behaviour, whereas
wild-type readily displayed mounting behaviour, even at higher fre-
quencies, as observed in gonadally intact wild-type male mice of
the same strain (Fig. 1B). Adding oestradiol stimulated some mount-
ing behaviour in ArKO females, but not up to the levels observed in
wild-type females. Thus, there is no clear behavioural evidence for
brain masculinisation in ArKO females. Indeed, it may be argued
that female mounting behaviour is actually a female-typical
behavioural characteristic that also needs to be feminised by oes-
tradiol during early development, and thus not, as it is traditionally
thought, a typical male behavioural characteristic only. The etholog-
ical significance of female–female mounting behaviour is of course
less clear when compared to male–female mounting behaviour,
although it might signal dominance and reproductive status.
In summary, the results obtained on lordosis behaviour in ArKO
females are best explained by assigning an active role for oestradiol
in female-typical behavioural differentiation. At present, these
results provide the best available evidence for a role of oestradiol
in the development of the female brain.
Reduced kisspeptin expression in female ArKO mice
In recent years, the Kiss1 gene product, kisspeptin, has been pro-
posed as an important upstream regulator of the gonadotrophin-
releasing hormone (GnRH) system because human patients did not
enter into puberty as a result of a mutation in the GPR54 gene
(29), which encodes the kisspeptin receptor, named GPR54 (now
named Kiss1r). Similar results were obtained in mice with a tar-
geted disruption of the Kiss1 gene (30). Interestingly, kisspeptin
expression is sexually dimorphic in rodent species, with females
having greater numbers of kisspeptin-expressing neurones than
males in the rostral periventricular area of the third ventricle
(RP3V) (31, 32) suggesting that kisspeptin may play a sexually
dimorphic role in controlling reproductive events. In particular, the
RP3V kisspeptin population has been proposed to play a critical role
in the positive-feedback actions of oestradiol on GnRH release.
Because ArKO females were reported to be unable to ovulate (25,
27), we determined whether the sexual differentiation of the RP3V
kisspeptin population was affected in ArKO female mice. In addi-
tion, because we observed several changes in olfactory functioning
in female ArKO mice (24, 33, 34), we investigated whether the inte-
gration of pheromones into the reproductive system was affected
in ArKO female mice and thus whether oestradiol may be important
in organising sexually dimorphic responses of the reproductive sys-
tem, such as LH release, to pheromones. Exposure to male phero-
mones induced Fos protein in RP3V kisspeptin neurones in ArKO
female mice, albeit significantly less compared to wild-type females
(Fig. 2A). The sexual differentiation of kisspeptin neuronal number
was lost in ArKO females (Fig. 2B) (i.e. the number of kisspeptin-








































































Fig. 2. Effects of aromatase knockout (ArKO) on the sexual differentiation
of kisspeptin neuronal numbers and their activation by same versus opposite
sex urinary pheromones. (A) Mean  SEM percentage of fos activated kiss-
peptin expressing neurones after exposure to either water, intact male or
oestrous female urine in the rostral periventricular area of the third ventricle
(RP3V) of female wild-type (WT) and ArKO mice. *P < 0.05 compared to
water exposure; #P < 0.05 compared to water exposure and wild-type
females exposed to male urine. (B) Mean  SEM number of kisspeptin neu-
rones in the RP3V. *P < 0.05 compared to ArKO females. Data adapted from
Bakker et al. (35).
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that observed in male mice), suggesting that the sex difference in
kisspeptin neuronal number in wild-type mice reflects an organisa-
tional action of oestradiol in females (35) because ArKO females
were supplemented with oestradiol in adulthood for these experi-
ments. This result was confirmed by a recent study performed by
Clarkson et al. (36), who showed that ovariectomy of female pups
at postnatal (P) day 15 resulted in a 70-90% reduction in kisspeptin
expression within the RP3V analyzed at either P30 or P60, whereas
oestradiol treatment in P15 ovariectomised mice from P15-P30 or
P22–P30 resulted in a complete restoration of kisspeptin expression
in this brain region. Furthermore, they showed decreased numbers
of kisspeptin neurones in the RP3V of adult female ArKO mice, as
was also observed in our study (35). These findings can be best
explained by organisational rather than activational effects of oes-
tradiol on kisspeptin neurones in the RP3V because earlier work
from this group showed that the RP3V kisspeptin population is not
present before P25 (31).
Interestingly, kisspeptin neurones in the RP3V were still activated
by male pheromones in ArKO females, although this activation was
clearly reduced in comparison with wild-type females. Whether
there is a link between this reduced activation of kisspeptin neuro-
nes and the lack of showing ovulation following adult oestradiol
treatment (27) is still unknown. We are currently determining
whether concurrent treatment with oestradiol and progesterone,
which has been shown to be successful in inducing LH surges in
wild-type female mice (37), can induce LH surges in ArKO female
mice.
In summary, these results clearly show that oestradiol induces a
female-typical population of kisspeptin in the RP3V and thus pro-
vides additional evidence for an organisational role of oestradiol in
female neural differentiation.
Reduced prepubertal expression of progesterone receptor
in the hypothalamus of female ArKO mice
The observation of clear deficits in lordosis behaviour (24), as well
as decreased numbers of kisspeptin neurones in the RP3V (35) of
female ArKO mice, has resurrected the question of whether oestra-
diol, acting during the first several weeks of life, actively contrib-
utes to female-typical brain and behavioural sexual differentiation,
perhaps beginning after postnatal day 7 when the ovary first pro-
duces oestradiol (38) and when the AFP concentration has dimin-
ished to such an extent that it no longer plays a neuroprotective
role against oestrogens. One approach to the question of whether
oestradiol actively contributes to female development would be to
compare the expression of an oestradiol-dependent gene in ArKO
female mice, which produce no oestradiol in any tissue, and in
wild-type control females. The expression of the progesterone
receptor (PR) in the hypothalamus of adult female rodents is well
known to be dramatically up-regulated by oestradiol (39, 40). Like-
wise, Wagner and colleagues have conducted an extensive series of
experiments showing that the number of PR-immunoreactive (-ir)
cells in the medial preoptic area (MPOA), the lateral part of the
ventromedial hypothalamus (VMHvl) and the AVPV of both rat (41)
and mouse (42, 43) is significantly greater in neonatal males than
in females. Additional work from this group (40, 43) showed that
oestradiol, formed via the neural aromatisation of testosterone in
male neonates, is responsible for the higher, male-typical levels of
PR expression in the MPOA. Finally, another study from this group
(44) showed that administration of the aromatase inhibitor ATD
reduced PR-ir in the MPOA of male rats killed at the end of gesta-
tion. Therefore, based on these results, we used the expression of
PR-ir in three different hypothalamic regions (i.e. AVPV, MPOA and
VMHvl) as an index of the action of oestradiol action in the female
mouse brain across the first 25 days of postnatal development (45).
We found that the amount of PR-ir in the AVPV and MPOA was
significantly lower in ArKO female mice than in wild-type females
at several prepubertal ages, including postnatal day P15, P20 and
P25, but not neonatally at P0, P5, or P10 (Fig. 3) (45). Similarly, PR-
ir was significantly lower in the VMHvl at P25 in ArKO versus wild-
type females but not at earlier postnatal ages (45). We also
observed that PR-ir was consistently higher in male than in female
wild-type mice in the AVPV and MPOA over P0–P10 and in the
VMHvl over P0–P20. In addition, PR-ir in ArKO males was signifi-
cantly lower than in wild-type males in these brain areas across
these latter ages, and resembled the values observed in wild-type
females, confirming previous stusies indicating that oestradiol
formed in the male hypothalamus by aromatisation of testosterone
is responsible for inducing male-typical levels of neural PR
expression.
These results thus support the view that oestradiol contributes
prepubertally to at least one female-typical aspect of development
in both the MPOA and AVPV, namely the expression of PR (45).
However, more research is needed to determine whether this pre-
pubertal increase in neural PR expression observed in wild-type
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Fig. 3. Reduced prepubertal expression of progesterone receptor (PR) in the
hypothalamus of aromatase knockout (ArKO) mice. (A) The total number of
PR-immunoreactive (-ir) cells in the medial preoptic area (MPOA) at several
postnatal ages in female and male wild-type (WT) and ArKO mice. *P < 0.05
compared to ArKO mice of both sexes. Data adapted from Brock et al. (45).
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ovarian production of oestradiol or, alternatively, whether long-last-
ing morphological and ⁄ or behavioural neuroendocrine conse-
quences of this prepubertal oestrogenic stimulation of PR
expression can be identified in the female rodent MPOA and AVPV,
such as the development of the female-typical kisspeptin popula-
tion.
Interestingly, these results also indicate that oestradiol induces
both female- and male-typical expression of PR in the mouse hypo-
thalamus, with the male-typical population developing prenatally
and the female-typical population developing postnatally (Fig. 4).
These sex differences in expression (and particularly in the induc-
tion of PR expression) may simply reflect gonad development, with
the brain responding passively, and perhaps not some inherent
brain sex difference or sex difference in critical period.
Conclusions and future directions
The results obtained in female ArKO mice suggest an active contri-
bution of oestrogens to the development of the female brain. Ini-
tially, these results are at odds with our results obtained in AFP-
KO mice demonstrating that the principal action of prenatal oes-
trogen exposure, regardless of whether it occurs in female or male
mice, is to defeminise and to some extent masculinise brain and
behaviour. Thus, both knockout mouse models show feminising
and defeminising actions of oestradiol. Such a dual role of oestra-
diol in brain sexual differentiation was earlier suggested by Dohler
et al. (19) who introduced the ‘progressive hypothesis of brain sex-
ual differentiation’, which asserts that, under the influence of
moderate levels of oestradiol, female-typical neural and behavioural
traits develop, whereas, under the influence of high levels of oes-
tradiol, male-typical neural and behavioural traits develop. How-
ever, our results obtained in AFP-KO mice clearly show that any
prenatal oestrogen action is blocked by AFP during development
and, thus, in order for oestradiol to influence brain sexual differen-
tiation, it has to be produced locally from testosterone by aromati-
sation. So the next question would be that if oestradiol is acting
prenatally in the female brain, what might be the sources of this
oestradiol? It may be de novo synthesis (44) but, at present, the
evidence to support is still lacking. Another possibility is that
female-typical neural and behavioural characteristics develop post-
natally at the time that the ovaries have begun to produce oestra-
diol (after P7) and when the amount of AFP has decreased
substantially and AFP no longer plays a protective role (Fig. 4). Our
results obtained on PR expression clearly show that the female-
typical expression of PR develops after P10, which suggests that
feminising actions of oestradiol take place prepubertally and not
perinatally. Supportive evidence comes from the study by Clarkson
et al. (36) on the sexual differentiation of the RP3V kisspeptin pop-
ulation, showing that prepubertal treatment with 17b-oestradiol
between P15 and P30 was able to restore the decrease observed in
kisspeptin expression in P15-ovariectomised female mice. However,
the possibility cannot be ruled out that some prenatal or early









































Fig. 4. Working hypothesis on how oestradiol can have both feminising and defeminising effects on brain sexual differentiation. Thus, male-typical neural
and behavioural differentiation occurs prenatally in genetic males under the influence of testosterone and oestradiol, which is avoided in foetal genetic
females by the neuroprotective actions of a-fetoprotein (AFP), whereas female-typical neural and behavioural differentiation probably occurs postnatally in
genetic females under the influence of oestradiol that is presumably produced by the ovaries and at the time that AFP no longer plays a neuroprotective role.
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neonatal event is still necessary for mice to be able to later show
a female-typical response to oestradiol with regard to hypotha-
lamic kisspeptin and PR expression. The ArKO mouse will be a
great model to test whether there is a specific critical period for
female brain development because they can be supplemented with
oestradiol at various times during development. Studies are cur-
rently underway aiming to determine whether deficits in lordosis
behaviour can be reversed by prepubertal treatment with oestra-
diol. If normal wild-type levels of lordosis behaviour can be
induced in female ArKO mice by treating them with exogenous
oestradiol over a specific postnatal period, then these results would
provide the best evidence for an active contribution of oestradiol
to female neural and behavioural sexual differentiation.
Finally, the view that testosterone and ⁄ or oestradiol are solely
responsible for the development of sex differences in the mamma-
lian brain has been challenged as well. Several sex dimorphisms
have been identified that are difficult to attribute solely to the peri-
natal actions of sex steroids in the nervous system. Thus, it has
been proposed that different doses of genes expressed off the X
chromosome in XY (male) versus XX (female) mice influence aspects
of brain and behavioural sexual differentiation (46), perhaps reflect-
ing a nonhormonal, genetic signalling mechanism that actively pro-
motes female-typical brain sexual differentiation. For example, De
Vries et al. (47) showed that the male-typical profile of vasopressin
innervation of the lateral septum depends on the presence of a
Y-chromosome. XY males and XY female mice (i.e. females with a
deletion of the Sry gene) were more masculine than XX mice with
respect to the density of vasopressin-ir fibres in the lateral septum.
Our finding (6) of a female-like vasopressin innervation in the lat-
eral septum of female AFP-KO mice is intriguing because mice had
been exposed to high defeminising levels of oestradiol during pre-
natal development. Thus, more research is needed to determine the
contribution of chromosome genes to the sexual differentiation of
the brain.
At present, there is increasing evidence for an organisational role
of oestradiol in female-typical neural and behavioural sexual differ-
entiation, thereby challenging the old dogma of a default organisa-
tional programme for the female brain. However, more research is
needed on when oestradiol is precisely acting in the female brain
to induce feminisation (i.e. is there a specific critical time window
for female brain differentiation as has been shown for the develop-
ment of the male brain?). In addition, questions remain on the
mechanisms by which oestradiol induces feminisation (i.e. is there a
specific role for progesterone receptors as well as progesterone
itself in the development of the female brain?).
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